Clinical Trials | May 19, 2026
Access to genomic testing, not therapy cost, is the biggest challenge
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
The product is bioequivalent and therapeutically equivalent to the reference listed drug by Fresenius Kabi USA, LLC.
New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches
Antiviral injection addressing CMV and HSV infections had US market sales of nearly $15 million in the last 12 months
New facility ‘Amber Wing’ adds 55 beds and strengthens surgical, cardiac, robotic and preventive care infrastructure for women in Mumbai
The Ibuprofen business posted a negative EBITDA of Rs. 179 million in Q4 despite revenue rising 61% year-on-year to Rs. 849 million
Medanta expanded its bed capacity by 20% during the year
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
